(Q39016105)

8 September 2017

Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition (English)

1 reference

8 September 2017

1 reference

Huajie Zong

1

1 reference

8 September 2017

Baobing Yin

2

1 reference

8 September 2017

Huading Zhou

3

1 reference

8 September 2017

Duan Cai

4

1 reference

8 September 2017

Baojin Ma

5

1 reference

8 September 2017

Yang Xiang

6

1 reference

8 September 2017

13 March 2014

1 reference

Molecular Biology Reports

8 September 2017

1 reference

8 September 2017

41

1 reference

8 September 2017

7

1 reference

8 September 2017

4507-4512

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-014-3321-4

8 September 2017

0 references

cites work

Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Chemotherapy in gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Chemotherapy with gemcitabine in patients with gall-bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

The basics of epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Role of the epithelial-mesenchymal transition in bladder cancer: from prognosis to therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Therapeutic effect of rapamycin on gallbladder cancer in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Combination of rapamycin, CI-1040, and 17-AAG inhibits metastatic capacity of prostate cancer via Slug inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-014-3321-4

Curative resection in potentially resectable tumours of the gallbladder.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24623408

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neoadjuvant chemoradiotherapy in gallbladder cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24623408

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24623408

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11033-014-3321-4

1 reference

8 September 2017

1 reference